These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34276994)

  • 21. Clinical outcome of brain metastases differs significantly among breast cancer subtypes.
    Oehrlich NE; Spineli LM; Papendorf F; Park-Simon TW
    Oncol Lett; 2017 Jul; 14(1):194-200. PubMed ID: 28693153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
    Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
    Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry.
    Laakmann E; Witzel I; Scriba V; Grzyska U; Zu Eulenburg C; Burchardi N; Hesse T; Würschmidt F; Fehm T; Möbus V; von Minckwitz G; Loibl S; Park-Simon TW; Mueller V
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biological subtype predicts locoregional recurrence after postmastectomy radiotherapy in Chinese breast cancer patients.
    Wang J; Luo J; Jin K; Wang X; Yang Z; Ma J; Mei X; Wang X; Zhou Z; Yu X; Chen X; Guo X
    Cancer Med; 2020 Apr; 9(7):2427-2434. PubMed ID: 32048817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can breast cancer molecular subtype help to select patients for preoperative MR imaging?
    Grimm LJ; Johnson KS; Marcom PK; Baker JA; Soo MS
    Radiology; 2015 Feb; 274(2):352-8. PubMed ID: 25325325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
    Denkert C; von Minckwitz G; Darb-Esfahani S; Lederer B; Heppner BI; Weber KE; Budczies J; Huober J; Klauschen F; Furlanetto J; Schmitt WD; Blohmer JU; Karn T; Pfitzner BM; Kümmel S; Engels K; Schneeweiss A; Hartmann A; Noske A; Fasching PA; Jackisch C; van Mackelenbergh M; Sinn P; Schem C; Hanusch C; Untch M; Loibl S
    Lancet Oncol; 2018 Jan; 19(1):40-50. PubMed ID: 29233559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12).
    Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
    Breast Cancer Res Treat; 2021 Apr; 186(2):453-462. PubMed ID: 33392845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High risk factors of brain metastases in 295 patients with advanced breast cancer.
    Yan M; Lü HM; Liu ZZ; Liu H; Zhang MW; Sun XB; Cui SD
    Chin Med J (Engl); 2013 Apr; 126(7):1269-75. PubMed ID: 23557557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No association between triple-negative breast cancer and prognosis of patients receiving breast-conserving treatment.
    Mu L; Liu Y; Xiao M; Liu W; Liu M; Wang X
    Oncol Lett; 2017 Dec; 14(6):7862-7872. PubMed ID: 29250179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical characteristics and survival in the operable breast cancer patients with different molecular subtypes].
    Zhang HM; Zhang BN; Xuan LX; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):447-51. PubMed ID: 19950556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationships Between MRI Breast Imaging-Reporting and Data System (BI-RADS) Lexicon Descriptors and Breast Cancer Molecular Subtypes: Internal Enhancement is Associated with Luminal B Subtype.
    Grimm LJ; Zhang J; Baker JA; Soo MS; Johnson KS; Mazurowski MA
    Breast J; 2017 Sep; 23(5):579-582. PubMed ID: 28295860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
    Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
    Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of small T1a/b breast cancer by tumor subtype.
    Ignatov T; Eggemann H; Burger E; Costa SD; Ignatov A
    Breast Cancer Res Treat; 2017 May; 163(1):111-118. PubMed ID: 28233107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes by molecular subtype after accelerated partial breast irradiation using single-entry catheters.
    Saini A; Kuske R; Quiet C; Pantoja C; Reed D; Zannis V
    Brachytherapy; 2018; 17(2):415-424. PubMed ID: 29146102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast carcinoma subtypes show different patterns of metastatic behavior.
    Molnár IA; Molnár BÁ; Vízkeleti L; Fekete K; Tamás J; Deák P; Szundi C; Székely B; Moldvay J; Vári-Kakas S; Szász MA; Ács B; Kulka J; Tőkés AM
    Virchows Arch; 2017 Mar; 470(3):275-283. PubMed ID: 28101678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics and survival analysis of breast cancer molecular subtypes with hepatic metastases.
    Ge QD; Lv N; Kong YN; Xie XH; He N; Xie XM; Wei WD
    Asian Pac J Cancer Prev; 2012; 13(10):5081-6. PubMed ID: 23244114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes and recurrence patterns according to breast cancer subtypes in Korean women.
    Lee Y; Kang E; Lee AS; Baek H; Kim EK; Park SY; Kim JH; Kim YJ; Kim SH; Kim IA; Eom KY; Kim SW
    Breast Cancer Res Treat; 2015 May; 151(1):183-90. PubMed ID: 25893592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The breast graded prognostic assessment is associated with the survival outcomes in breast cancer patients receiving whole brain re-irradiation.
    Lai SF; Chen YH; Liang TH; Hsu CY; Lien HC; Lu YS; Huang CS; Kuo SH
    J Neurooncol; 2018 Jul; 138(3):637-647. PubMed ID: 29557535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential distribution of microRNAs in breast cancer grouped by clinicopathological subtypes.
    Li JY; Jia S; Zhang WH; Zhang Y; Kang Y; Li PS
    Asian Pac J Cancer Prev; 2013; 14(5):3197-203. PubMed ID: 23803104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.